Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Routine surveillance for symptomatic toxicities with real-time clinician reporting in Danish breast cancer patients-Organization and design of the first national, cluster randomized trial using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Early indicators of primary brain tumours: a population-based study with 10 years’ follow-up

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Optimal Systemic Treatment of Advanced Bladder Cancer-A Moving Target

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Gynaecological cancer leads to long-term sick leave and permanently reduced working ability years after diagnosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. The Use of Wearables in Clinical Trials During Cancer Treatment: Systematic Review

    Research output: Contribution to journalReviewResearchpeer-review

View graph of relations

The Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE) was developed by the National Cancer Institute to capture patient self-reports of symptomatic toxicities during cancer treatment. The aim of this short communication is to describe the design of a national study, which examine the effect of using patients' electronic PRO-CTCAE reporting with real-time feedback to clinicians on treatment events for breast cancer patients receiving adjuvant chemotherapy. The study's end-points are defined as dose reduction, hospitalization, and febrile neutropenia. This is the first report on the impact of PRO-CTCAE in a national breast cancer population during chemotherapy treatment.

Original languageEnglish
JournalBreast
Volume25
Issue number2
Pages (from-to)269-272
ISSN0960-9776
DOIs
Publication statusPublished - 2019

    Research areas

  • PRO-CTCAE, adjuvant chemotherapy, breast cancer, patient reported outcome, toxicity, Humans, Hospitalization, Neutropenia/chemically induced, Randomized Controlled Trials as Topic, Denmark, Female, Chemotherapy, Adjuvant/adverse effects, Breast Neoplasms/drug therapy, Patient Reported Outcome Measures

ID: 56584193